NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.
Corium International, Inc. CORI
Merger Announcement: October 11, 2018
Transaction Details: Corium will be purchased by Gurnet Point Capital. Under the terms of the transaction, Corium shareholders will receive $12.50 for each share of Corium stock they own. The agreement also provides for a Contingent Value Right of $0.50 per share payable upon certain conditions.
To learn more about the action and your rights, go to: https://www.zlk.com/mna/corium-international-inc.
Esterline Technologies Corporation ESL
Merger Announcement: October 10, 2018
Transaction Details: Esterline will be purchased by TransDigm Group Incorporated TDG. Under the terms of the transaction, Esterline shareholders will receive $122.50 for each share of Esterline stock they own.
To learn more about the action and your rights, go to: https://www.zlk.com/mna/esterline-technologies-corporation.
Imperva, Inc. IMPV
Merger Announcement: October 10, 2018
Transaction Details: Imperva, Inc. will be purchased by Thoma Bravo, LLC. Under the terms of the transaction, Imperva shareholders will receive $55.75 per share.
To learn more about the action and your rights, go to: https://www.zlk.com/mna/imperva-inc.
Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
jlevi@levikorsinsky.com
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.